Integra LifeSciences Holdings Corporation (IART) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Integra LifeSciences Holdings Corporation (IART) closed at USD 13.18 on 2026-10-14, a change of -15.3 % over the past year, with a market capitalization of USD 1.05B.

Integra LifeSciences Holdings Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Integra LifeSciences Holdings Corporation key figures

Previous close

USD 13.18 (2026-10-14)

1-year change

-15.3 %

Market cap

USD 1.05B

Enterprise value

USD 2.83B

P/E ratio (trailing)

-150.33

P/E ratio (forward)

5.32

EPS (trailing)

-0.09

EPS (forward)

2.54

PEG ratio

0.67

Price to book

1.01

Revenue growth

0.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

8.11

Employees

4,427

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Integra LifeSciences Holdings Corporation and compare it with other stocks.